Filing Flows › America Great Health (AAGH) › Q3 FY26 › vs Q3 FY25
America Great Health (AAGH) Q3 FY26 vs Q3 FY25 (year over year)
America Great Health's revenue fell $30K (-53%) from $56K in Q3 FY25 to $26K in Q3 FY26. The biggest changes: Anti Aging Immune Support −$36K (-72%); Targeted System Support +$4K (+57%); Herbal Insulin Support +$2K (—).
America Great Health, Q3 FY26: revenue $26K (-53% year over year), operating margin -282.2%, net loss $166K, operating cash flow $2K. The chart draws each line against Q3 FY25, the increases inside each band.
Every line
| Line | Q3 FY26 | Q3 FY25 | Change | % |
|---|---|---|---|---|
| Anti Aging Immune Support | $14K | $50K | −$36K | -72% |
| Targeted System Support | $10K | $6K | $4K | +57% |
| Herbal Insulin Support | $2K | $0 | $2K | — |
| Revenue | $26K | $56K | −$30K | -53% |
| Net loss | $166K | $158K | $8K | +5% |
| Costs & expenses | $192K | $215K | −$22K | -10% |
| Operating costs | $100K | $141K | −$42K | -29% |
| Interest & other, net | $92K | $73K | $19K | +27% |
| Cost of revenue | $4K | $6K | −$3K | -43% |
| Operating expenses | $96K | $135K | −$39K | -29% |
| Operating cash sources | $168K | $105K | $63K | +60% |
| Depreciation | $1K | $4K | −$3K | -74% |
| Working capital & other | $167K | $101K | $66K | +65% |
| Net loss absorbed | $166K | $158K | $8K | +5% |
| Operating cash flow | $2K | −$53K | $55K | — |
Questions
How much did America Great Health's revenue grow year over year in Q3 FY26?
America Great Health's revenue fell $30K (-53%) from $56K in Q3 FY25 to $26K in Q3 FY26.
What drove America Great Health's revenue change in Q3 FY26?
Anti Aging Immune Support −$36K (-72%); Targeted System Support +$4K (+57%); Herbal Insulin Support +$2K (—).